Drew Weissman, Nobel-winning mRNA pioneer
Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.
Oct 2, 2023
0
33
Drew Weissman's decades of research into mRNA technology paved the way for COVID-19 vaccines, finally earning a Nobel prize for the physician-scientist.
Oct 2, 2023
0
33
Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
Researchers from Uppsala University have revealed one of the mechanisms behind the growth of cancer cells in the blood cancer multiple myeloma. The study shows that the protein EZH2 interacts with a specific RNA molecule ...
Sep 29, 2023
0
2
Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production ...
Sep 29, 2023
0
68
A biobank for all, in which a person from any background could find a bone marrow donor for a stem cell transplant, is a major goal for stem cell science. While repositories of cell lines that could be a match for most patients ...
Sep 28, 2023
0
17
A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice.
Sep 27, 2023
0
8
Earlier this month, health authorities confirmed that BA.2.86, a highly mutated variant of the virus that causes COVID-19, is at risk of spreading rapidly in countries around the world. With updated shots rolling out this ...
Sep 22, 2023
0
17
A leukemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR)—meaning they are effectively cured of the disease.
Sep 12, 2023
0
8
Since its discovery in 1910, sickle cell disease has been considered a death sentence for those that inherited it. But over the years, dedicated pediatric programs and research initiatives have greatly improved patient care ...
Sep 11, 2023
0
1
A new study published in Nature Genetics led by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant hematopoietic stem cells.
Sep 8, 2023
0
253